Pablo
Irimia Sieira
Consultor Médico
Hospital del Mar
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital del Mar (4)
2024
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937
2021
-
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Journal of Headache and Pain, Vol. 22, Núm. 1